Hongchang Technology: Net profit in 2025 is expected to decrease by 37.41% year-on-year, with a proposed dividend of 0.28 RMB per 10 shares.

MetaMuskRat · 2026-04-06T08:50:48+00:00

People's Financial News, April 6 — Hongchang Technology (301008) disclosed its annual report on April 6, 2025, with an operating revenue of 1.15B yuan, an increase of 11.68% year-over-year; net profit attributable to shareholders of the parent company was 32.8364 million yuan, a decrease of 37.41% year-over-year; basic earnings per share were 0.27 yuan. The company plans to distribute a cash dividend of 0.28 yuan per 10 shares (tax included). In 2026, the company completed a controlling stake in Liangzhi Joint Company. The robotics-related component business is one of the company's key future investment directions. Currently, Liangzhi Joint has actively engaged with major domestic humanoid robot companies, achieving partial technical integration, sample testing, and small-batch deliveries. Due to the R&D and testing progress of downstream clients, the overall scale remains small. If downstream clients begin to steadily and sustainably increase volume, and Liangzhi Joint’s quality and production capacity can align with customer demand, the robotics-related component business will experience rapid growth.

MetaMuskRat

2026-04-06 08:50:48

People’s Finance and News, April 6—Hongchang Technology (301008) disclosed its annual report on April 6. In 2025, the company achieved operating revenue of 1.15B yuan, up 11.68% year over year; net profit attributable to shareholders was 32.8364 million yuan, down 37.41% year over year; and basic earnings per share were 0.27 yuan. The company plans to distribute a cash dividend of 0.28 yuan for every 10 shares (tax included). In 2026, the company will complete its acquisition of a controlling stake in Liangzhi Joint Company. Robot-related components business is one of the company’s key areas for future investment. Currently, Liangzhi Joint Company has actively connected with major domestic humanoid robot companies and has already partially completed technical integration, sample testing, and small-batch deliveries. Due to limitations from the R&D and testing progress of downstream customers, the overall scale remains small. If downstream customers begin to ramp up volume steadily and continuously, and if Liangzhi Joint’s quality and production capacity can be aligned with customers’ demands, the robot-related components business will experience relatively rapid growth.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes